FAS and autoimmune lymphoproliferative syndrome: In the present study, we demonstrated that stabilized β-catenin slightly rescued some Fas-mutation-mediated ALPS-like manifestations, especially the double-negative T (TCRβ+CD4−CD8−) cells, by regulating the Fas-independent-mediated apoptosis pathway, uncovering a potential novel therapeutic direction for ALPS.